Modernizing Drug Enforcement Act of 2019
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (May 8, 2019)
Modernizing Drug Enforcement Act of 2019
This bill deems a drug or substance that acts as an opioid mu receptor agonist (e.g., morphine) to be in schedule I of the Controlled Substances Act, subject to certain exceptions. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.
What just happenedMay 31, 2019
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Who’s behind it
- Introduced in HouseMay 8, 2019
- May 31, 2019Committee
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Crime and Federal Government Surveillance Subcommittee - May 9, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - May 8, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Judiciary Committee - May 8, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - May 8, 2019IntroReferralIntro-H
Introduced in House
- May 8, 2019IntroReferral1000
Introduced in House